tirzepatide and stroke Stroke: GLP-1s Like Ozempic, Mounjaro May Reduce Cardiovascular Risks UC Irvine researchers project cardiac

Meanwhile, tirzepatide (Zepbound) is specifically approved to address obstructive sleep apnea in adults with obesity

To ensure the highest standards of factual accuracy and reliability, all SneakPeek blog content is meticulously reviewed by our experienced internal team

In people with type 2 diabetes at high cardiovascular risk, 104 weeks of treatment with tirzepatide was associated with reduced albuminuria and a slower decline in eGFR compared with treatment with insulin glargine

doi: 10.1128/JB.02169-12 67 JezykM

While still in trial, side effects reported have been similar to existing GLP-1 medications, typically mild gastrointestinal issues